Provided by Tiger Fintech (Singapore) Pte. Ltd.

Processa Pharmaceuticals, Inc.

0.3060
-0.0541-15.02%
Post-market: 0.30990.0039+1.27%19:57 EDT
Volume:6.07M
Turnover:1.93M
Market Cap:15.41M
PE:-0.19
High:0.3637
Open:0.3600
Low:0.2901
Close:0.3601
52wk High:1.50
52wk Low:0.1500
Shares:50.35M
Float Shares:35.01M
Volume Ratio:0.64
T/O Rate:17.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6310
EPS(LYR):-3.8727
ROE:-212.38%
ROA:-102.62%
PB:2.52
PE(LYR):-0.08

Loading ...

Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight?

Benzinga
·
Oct 08

Processa Pharmaceuticals Inc. Concluded Special Shareholder Meeting

Reuters
·
Sep 12

Processa Pharmaceuticals Inc. Held Special Shareholder Meeting

Reuters
·
Sep 03

Processa Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Sep 02

Processa Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $1 From $2

THOMSON REUTERS
·
Sep 02

Processa Pharmaceuticals Inc. Announces Date for Special Stockholders Meeting

Reuters
·
Aug 13

Processa Pharmaceuticals Granted Extension to Regain Nasdaq Compliance Amid Bid Price Challenge

Reuters
·
Aug 09

Processa Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
Aug 09

Processa Pharma Q2 EPS $(0.25) Misses $(0.20) Estimate

Benzinga
·
Aug 08

BRIEF-Processa Pharmaceuticals Secures Strategic Investment And Evaluates Corporate Crypto Treasury Strategies

Reuters
·
Aug 07

Processa Pharmaceuticals Expands Strategic Financial Approaches with Cryptocurrency Treasury Strategy Evaluation

Reuters
·
Aug 07

Processa Pharmaceuticals Inc. Announces Prospectus Supplement for $5.24M in Common Stock Sales, $1.55M Sold in Past Year

Reuters
·
Jul 26

Processa Pharmaceuticals Inc. Conducted Annual Shareholders Meeting

Reuters
·
Jul 19

Processa Pharmaceuticals Inc. Convened Annual Shareholder Meeting

Reuters
·
Jul 16

BRIEF-Processa Pharmaceuticals Terminates Licensing Agreement With Ocuphire Pharma - SEC Filing

Reuters
·
Jul 01

BRIEF-Processa Pharmaceuticals Provides Portfolio And Business Update

Reuters
·
Jul 01

Processa Pharmaceuticals Announces New Phase 2 Clinical Trial Enrollment for Metastatic Breast Cancer Treatment

Reuters
·
Jul 01

Processa Pharmaceuticals Inc. Reconvened Annual Shareholder Meeting

Reuters
·
Jul 01

Processa Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 30

Processa Pares Gains on Equity Offer News

Dow Jones
·
Jun 18